Suppr超能文献

硝苯地平(NIF)和尼索地平(NIS)单药治疗及联合β受体阻滞剂治疗原发性高血压患者的疗效和耐受性:一项多中心、平行组研究。

The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with a beta-blocker in patients with essential hypertension: a multicenter, parallel-group study.

作者信息

Rosenfeld J B, Zabludowski J

机构信息

Blood Pressure and Renal Unit, Bellinson Medical Center, Petah Tikva, Israel.

出版信息

J Clin Pharmacol. 1989 Nov;29(11):1013-6. doi: 10.1002/j.1552-4604.1989.tb03271.x.

Abstract

We have assessed the efficacy and tolerance of Nifedipine twice daily and Nisoldipine once daily, both alone and in combination with a beta-blocker in 171 essential hypertensives in a randomized parallel comparison fashion. Both drugs were equally effective in lowering blood pressure: 72.6% of the subjects on Nisoldipine and 80.5% of those on Nifedipine reached a supine diastolic blood pressure less than or equal to 90 mmHg. Spontaneously reported side effects were frequent but no biochemical, hematological or electrocardiographic abnormalities were detected.

摘要

我们采用随机平行对照的方式,评估了硝苯地平每日两次以及尼索地平每日一次单药治疗及与β受体阻滞剂联合治疗171例原发性高血压患者的疗效和耐受性。两种药物在降低血压方面同样有效:服用尼索地平的患者中有72.6%、服用硝苯地平的患者中有80.5%的仰卧位舒张压降至小于或等于90mmHg。自发报告的副作用很常见,但未检测到生化、血液学或心电图异常。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验